{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T17:56:28Z","timestamp":1781718988092,"version":"3.54.5"},"reference-count":39,"publisher":"Norwegian Medical Association","issue":"23","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tidsskr Nor Legeforen","Tidsskriftet"],"published-print":{"date-parts":[[2009,12,3]]},"DOI":"10.4045\/tidsskr.09.0190","type":"journal-article","created":{"date-parts":[[2009,12,9]],"date-time":"2009-12-09T06:10:26Z","timestamp":1260339026000},"page":"2484-7","source":"Crossref","is-referenced-by-count":0,"title":["Immunrekonstitusjonssyndrom ved behandling av hivinfeksjon"],"prefix":"10.4045","volume":"129","author":[{"given":"Marius","family":"Troseid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arne","family":"Eskesen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan N.","family":"Bruun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2479","reference":[{"key":"1920662_ref_1","first-page":"3121","volume":"126","author":"Bruun","year":"2006","journal-title":"Tidsskrift for Den norske legeforening"},{"key":"1920662_ref_2","doi-asserted-by":"crossref","unstructured":"Lipman M, Breen R. Immune reconstitution inflammatory syndrome in HIV. Curr Opin Infect Dis 2006; 19: 20-5.","DOI":"10.1097\/01.qco.0000200543.80712.01"},{"key":"1920662_ref_3","unstructured":"Sexton DJ, Pien B. Immune reconstitution inflammatory syndrome. www.uptodate.com (31.1.2008)."},{"key":"1920662_ref_4","doi-asserted-by":"crossref","unstructured":"Dhasmana DJ, Dheda K, Ravn P et al. Immune reconstitution inflammatory syndrome in HIV-infected patients receiving antiretroviral therapy. Pathogenesis, clinical manifestetions and management. Drugs 2008; 68: 191-208.","DOI":"10.2165\/00003495-200868020-00004"},{"key":"1920662_ref_5","doi-asserted-by":"crossref","unstructured":"French MA. Immune reconstitution inflammatory syndrome: a reappraisal. Clin Infect Dis 2009; 48: 101-7.","DOI":"10.1086\/595006"},{"key":"1920662_ref_6","doi-asserted-by":"crossref","unstructured":"Lawn SD, Bekker LG, Miller RF. Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals. Lancet Infect Dis 2005; 5: 361-73.","DOI":"10.1016\/S1473-3099(05)70140-7"},{"key":"1920662_ref_7","doi-asserted-by":"crossref","unstructured":"Ratnam I, Chiu C, Kandala NB et al. Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type-1 infected cohort. Clin Infect Dis 2006; 42: 418-27.","DOI":"10.1086\/499356"},{"key":"1920662_ref_8","doi-asserted-by":"crossref","unstructured":"Manabe YC, Campbell JD, Sydnor E et al. Immune reconstitution inflammatory syndrome: risk factors and treatment implications. J Acquir Immune Defic Syndr 2007; 46: 456-62.","DOI":"10.1097\/QAI.0b013e3181594c8c"},{"key":"1920662_ref_9","doi-asserted-by":"crossref","unstructured":"Breton G, Duval X, Estella C et al. Determinants of immune reconstitution inflammatory syndrome in HIV type 1-infected patients with tuberculosis after antiretroviral therapy. Clin Infect Dis 2004; 39: 1709-12.","DOI":"10.1086\/425742"},{"key":"1920662_ref_10","unstructured":"Hoffmann C. Immune reconstitution inflammatory syndrome (IRS). HIV Medicine 2007; 15. utg.: 458-62. www.hivmedicine.com (10.6.2008)."},{"key":"1920662_ref_11","doi-asserted-by":"crossref","unstructured":"Murdoch DM, Venter WD, Feldman C et al. Incidence and risk factors for the immune reconstitution inflammatory syndrome in HIV patients in South Africa: a prospective study. AIDS 2008; 22: 601-10.","DOI":"10.1097\/QAD.0b013e3282f4a607"},{"key":"1920662_ref_12","doi-asserted-by":"crossref","unstructured":"Elston JW, Thaker H. Immune reconstitution inflammatory syndrome. Int J STD AIDS 2009; 20: 221-4.","DOI":"10.1258\/ijsa.2008.008449"},{"key":"1920662_ref_13","doi-asserted-by":"crossref","unstructured":"Price P, Keane NM, Stone SF et al. MHC haplotypes affect the expression of opportunistic infections in HIV patients. Hum Immunol 2001; 62: 157-64.","DOI":"10.1016\/S0198-8859(00)00239-1"},{"key":"1920662_ref_14","doi-asserted-by":"crossref","unstructured":"Price P, Morahan G, Huang D et al. Polymorphisms in cytokine genes define subpopulations of HIV-1 patients who experienced immune restoration diseases. AIDS 2002; 16: 2043-47.","DOI":"10.1097\/00002030-200210180-00009"},{"key":"1920662_ref_15","first-page":"2712","volume":"127","author":"Tr\u00f8seid","year":"2007","journal-title":"Tidsskrift for Den norske legeforening"},{"key":"1920662_ref_16","doi-asserted-by":"crossref","unstructured":"Lawn SD, Myer L, Bekker LG et al. Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control. AIDS 2006; 20: 1605-12.","DOI":"10.1097\/01.aids.0000238406.93249.cd"},{"key":"1920662_ref_17","doi-asserted-by":"crossref","unstructured":"Lawn SD, Wilkinson RJ, Lipman MC et al. Immune reconstitution and \u00abunmasking\u00bb of tuberculosis during antiretroviral therapy. Am J Respir Crit Care Med 2008; 177: 680-5.","DOI":"10.1164\/rccm.200709-1311PP"},{"key":"1920662_ref_18","doi-asserted-by":"crossref","unstructured":"Gkonos PJ, London R, Hendler ED. Hypercalcemia and elevated 1,25-dihydroxyvitamin D levels in a patient with end-stage renal disease and active tuberculosis. N Engl J Med 1984; 311: 1683-5.","DOI":"10.1056\/NEJM198412273112607"},{"key":"1920662_ref_19","unstructured":"Mgusi M, Villamor E, Urassa W et al. HIV co-infection, CD4 cell counts and clinical correlates of bacillary density in pulmonary tuberculosis. Int J Tuberc Lung Dis 2006; 10: 663-9."},{"key":"1920662_ref_20","doi-asserted-by":"crossref","unstructured":"Perlman DC, el-Sadr WM, Nelson ET et al. Variation of chest radiographic patterns in pulmonary tuberculosis by degree of human virus-related immunosuppression. Clin Infect Dis 1997; 25: 242-6.","DOI":"10.1086\/514546"},{"key":"1920662_ref_21","doi-asserted-by":"crossref","unstructured":"Karevellas MP, Azen SP, Macdonal JC et al. Immune recovery vitritis and uveitis in AIDS: clinical predictors, sequelae, and treatment outcomes. Retina 2001; 21: 1-9.","DOI":"10.1097\/00006982-200102000-00001"},{"key":"1920662_ref_22","doi-asserted-by":"crossref","unstructured":"Wright ME, Suzman DL, Csaky KG et al. Extensive retinal neovascularisation as a late finding in human immunodeficiency virus-infected patients with immune recovery uveitis. Clin Infect Dis 2003; 36: 1063-6.","DOI":"10.1086\/374050"},{"key":"1920662_ref_23","doi-asserted-by":"crossref","unstructured":"Stone SF, Price P, Tay-Kearney ML et al. Cytomegalovirus (CMV) retinitis restoration disease occurs during highly active antiretroviral therapy-induced restoration of CMV-specific immune responses within a predominant Th2 cytokine environment. J Infect Dis 2002; 185: 1813-7.","DOI":"10.1086\/340636"},{"key":"1920662_ref_24","doi-asserted-by":"crossref","unstructured":"Hsieh SM, Pan SC, Hung CC et al. Association between cytomegalovirus-specific reactivity of T cell subsets and development of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome. J Infect Dis 2001; 184: 1386-91.","DOI":"10.1086\/324419"},{"key":"1920662_ref_25","doi-asserted-by":"crossref","unstructured":"Jacobson MA, Zegans M, Pavan PR et al. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy. Lancet 1997; 349: 1443-5.","DOI":"10.1016\/S0140-6736(96)11431-8"},{"key":"1920662_ref_26","doi-asserted-by":"crossref","unstructured":"Jenny-Avital ER, Abadi M. Immune reconstitution cryptococcosis after initiation of successful highly active antiretroviral therapy. Clin Infect Dis 2002; 35: e128-e133.","DOI":"10.1086\/344467"},{"key":"1920662_ref_27","doi-asserted-by":"crossref","unstructured":"Saag M, Graybill RJ, Larsen RA et al. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America. Clin Infect Dis 2000; 30: 710-8.","DOI":"10.1086\/313757"},{"key":"1920662_ref_28","doi-asserted-by":"crossref","unstructured":"Blanche P, Gombert B, Ginsburg C et al. HIV combination therapy: immune restitution causing cryptococcal lymphadenitis dramatically improved by anti-inflammatory therapy. Scand J Infect Dis 1998; 30: 615-6.","DOI":"10.1080\/00365549850161223"},{"key":"1920662_ref_29","doi-asserted-by":"crossref","unstructured":"Boelaert JR, Goddeeris KH, Vanopdenbosch LJ et al. Relapsing meningitis caused by persistent cryptococcal antigens and immune reconstitution after the initiation of highly active antiretroviral therapy. AIDS 2004; 18: 1223-4.","DOI":"10.1097\/00002030-200405210-00023"},{"key":"1920662_ref_30","doi-asserted-by":"crossref","unstructured":"Wislez M, Bergot E, Antoine M et al. Acute respiratory failure following HAART introduction in patients treated for Pnemocystis carinii pneumonia. Am J Respir Crit Care Med 2001; 164: 847-51.","DOI":"10.1164\/ajrccm.164.5.2007034"},{"key":"1920662_ref_31","doi-asserted-by":"crossref","unstructured":"Zolopa A, Andersen J, Powderly W et al. Early antiretroviral therapy reduces AIDS progression\/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial. PLoS One 2009; 4: e5575.","DOI":"10.1371\/journal.pone.0005575"},{"key":"1920662_ref_32","doi-asserted-by":"crossref","unstructured":"Grant P, Zolopa A. Initiation of antiretroviral therapy in the hospitalised patient with an acute AIDS-related opportunistic infection and other conditions: no time to lose. Curr HIV\/AIDS Rep 2009; 6: 63-7.","DOI":"10.1007\/s11904-009-0010-3"},{"key":"1920662_ref_33","doi-asserted-by":"crossref","unstructured":"Dean GL, Edwards SG, Ives NJ et al. Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy. AIDS 2002; 16: 75-83.","DOI":"10.1097\/00002030-200201040-00010"},{"key":"1920662_ref_34","doi-asserted-by":"crossref","unstructured":"Dheda K, Lampe FC, Johnson MA et al. Outcome of HIV-associated tuberculosis in the era of highly active antiretroviral therapy. J Infect Dis 2004; 190: 1670-6.","DOI":"10.1086\/424676"},{"key":"1920662_ref_35","unstructured":"World Health Organisation. Antiretroviral therapy for HIV infection in adults and adolescents. Gen\u00e8ve: WHO, 2006."},{"key":"1920662_ref_36","unstructured":"Folkehelseinstituttet. Revidert kapittel: 10.3. Behandling og forebygging av tuberkulose hos hivsmittede i Smittevern 7. www.fhi.no (19.5.2009)."},{"key":"1920662_ref_37","doi-asserted-by":"crossref","unstructured":"Graybill JR, Sobel J, Saag M et al. Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. Clin Infect Dis 2000; 30: 47-53.","DOI":"10.1086\/313603"},{"key":"1920662_ref_38","doi-asserted-by":"crossref","unstructured":"King MD, Perlino CA, Cinnamon J et al. Paradoxial recurrent meningitis following therapy of cryptococcal meningitis: an immune reconstitution syndrome after initiation of highly active antiretroviral therapy. Int J STD AIDS 2002; 13: 724-6.","DOI":"10.1258\/095646202760326516"},{"key":"1920662_ref_39","doi-asserted-by":"crossref","unstructured":"Burman WJ, Jones BE. Treatment of HIV-related tuberculosis in the era of effective antiretroviral therapy. Am J Respir Crit Care Med 2001; 164: 7-12.","DOI":"10.1164\/ajrccm.164.1.2101133"}],"container-title":["Tidsskrift for Den norske legeforening"],"original-title":[],"language":"no","deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T17:31:07Z","timestamp":1781717467000},"score":1,"resource":{"primary":{"URL":"https:\/\/tidsskriftet.no\/2009\/12\/oversiktsartikkel\/immunrekonstitusjonssyndrom-ved-behandling-av-hivinfeksjon"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,3]]},"references-count":39,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2009,12,3]]}},"URL":"https:\/\/doi.org\/10.4045\/tidsskr.09.0190","relation":{},"ISSN":["0029-2001","0807-7096"],"issn-type":[{"value":"0029-2001","type":"print"},{"value":"0807-7096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,3]]}}}